(a)-PHCCC, a positive allosteric modulator of mGlu4 characterization, mechanism of action, and neuroprotection

From WikiCitingRetracted
Revision as of 09:43, 15 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == (a)-PHCCC, a positive allosteric modulator of mGlu4 characterization, mechanism of action, and neuroprotection; M Maj, V Bruno, Z Dragic, Yamamoto, G Battagliaae; 2003; doi_citing_unknown == Retraction == Neuroprotection Mediated by Glial Group-II Metabotropic Glutamate Receptors Requires the Activation of the MAP Kinase and the Phosphatidylinositol-3-kinase Pathways ; Mara D'Onofrio Laura Cuomo Giuseppe Battaglia Richard Teke Ngomba Mariana S...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Target Article[edit | edit source]

(a)-PHCCC, a positive allosteric modulator of mGlu4 characterization, mechanism of action, and neuroprotection; M Maj, V Bruno, Z Dragic,  Yamamoto, G Battagliaae; 2003; doi_citing_unknown

Retraction[edit | edit source]

Neuroprotection Mediated by Glial Group-II Metabotropic Glutamate Receptors Requires the Activation of the MAP Kinase and the Phosphatidylinositol-3-kinase Pathways  ; Mara D'Onofrio Laura Cuomo Giuseppe Battaglia Richard Teke Ngomba Mariana Storto Ann E Kingston; 08/01/2001

https://doi.org/10.1046/j.1471-4159.2001.00435.x

Citation piece[edit | edit source]

Note: Open to append information.

Retrieved from "https://wikicitingretracted.org/index.php?title=(a)-PHCCC,_a_positive_allosteric_modulator_of_mGlu4_characterization,_mechanism_of_action,_and_neuroprotection&oldid=18239"